Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.02 % |
3 Month Return | -1.07 % |
1 Year Return | -5.34 % |
Market Stats | |
Previous Close | ₹109.71 |
Open | ₹110.61 |
Volume | 99.80K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹534.57Cr |
P/E Ratio | 29.89 |
PEG Ratio | -91.52 |
Market Cap | ₹534.57 Cr |
P/B Ratio | 2.01 |
EPS | 3.54 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 7.87 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹534.57 Cr | 1.32% | 0.66 | ₹17 Cr | ₹367 Cr | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Zim Laboratories Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Zim Laboratories Ltd
Zim Laboratories reported a 7.8% decrease in revenue, with net income down by 29% and profit margin decreasing from 6.1% to 4.7% in FY 2024. EPS also decreased from ₹5.02 to ₹3.54. The Outside India segment contributed 78% of total revenue. Zim Laboratories shares are up 7.0% from a week ago.
ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024
An article suggests that ZIM Laboratories' free cash flow was significantly lower than its statutory profit, with a negative free cash flow of ₹576m over the last year. The company's earnings per share have grown impressively in the last three years, but investors are advised to analyze risks and warnings before investing.
ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024
ZIM Lab's standalone net sales for March 2024 increased by 12.39% YoY, with a quarterly net profit of Rs. 7.89 crore, up 10.51% from the previous year. The company's EPS has also increased to Rs. 1.62 in March 2024. However, ZIM Lab shares have given negative returns of -5.65% over the last six months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 147.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.26% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 89.1%
Profit Down
Netprofit is down for the last 2 quarters, 8.09 Cr → 0.9 Cr (in ₹), with an average decrease of 88.9% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 66.73% to 66.63% in Jun 2024 quarter
Price Dip
In the last 1 year, ZIMLAB stock has moved down by -5.3%
FII Holding Down
Foreign Institutions have decreased holdings from 0.01% to 0.00% in Jun 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 119.4 Cr → 82.82 Cr (in ₹), with an average decrease of 30.6% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 33.26% | 0.00 | |
Foreign Institutions | 0% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 66.63% | ||
Others | 0.11% | 0.00 |
Zim Laboratories Ltd in the last 5 years
Lowest (6.12x)
June 11, 2018
Today (29.89x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (198.80x)
July 1, 2021
Zim Laboratories Ltd’s net profit jumped 291.3% since last year same period to ₹0.90Cr in the Q1 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated -88.88% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.37%.
Read More about DividendsBearish
Neutral
Bullish
Zim Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Zim Laboratories Ltd (ZIMLAB) share price today is ₹109.8
Zim Laboratories Ltd is listed on NSE
Zim Laboratories Ltd is listed on BSE
PE Ratio of Zim Laboratories Ltd is 29.89
PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share
Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 99.80K.
Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹534.57Cr.
Zim Laboratories Ltd(ZIMLAB | Price |
---|---|
52 Week High | ₹131.4 |
52 Week Low | ₹89.5 |
Zim Laboratories Ltd(ZIMLAB) share price is ₹109.8. It is down -16.44% from its 52 Week High price of ₹131.4
Zim Laboratories Ltd(ZIMLAB) share price is ₹109.8. It is up 22.68% from its 52 Week Low price of ₹89.5
Zim Laboratories Ltd(ZIMLAB | Returns |
---|---|
1 Day Returns | 0.09% |
1 Month Returns | 0.02% |
3 Month Returns | -1.07% |
1 Year Returns | -5.34% |